Role of Nanotechnology in the Diagnosis and Treatment of Waterborne Diseases
Abstrakt
Nanotechnology provides new aspects for the treatment and diagnosis of diseases using atomic scale engineering of materials. The size of nanoparticles is similar to that of most biological molecules and structures; therefore, nanoparticles can be useful for both in vivo and in vitro biomedical research and applications. At the same time, the unique dimension of nanoparticles empowers them with special capabilities to successfully deliver the drug at the desired site. The integration of nanotechnology with biology has led to the development of diagnostic devices, contrast agents, analytical tools, physical therapy applications, and drug delivery vehicles. Water borne diseases are responsible for 4.0% of total annual deaths around the world. In the light of latest research, nanotechnology-based diagnosis and treatment have been proved as more effective and sensitive in comparison to the traditional methods. The unique nanoparticle-conjugated antibiotics are more efficient in showing their effect in comparison to the administration of the latter alone. At the same time, nanoparticle-labeled bio-sensors have proved their efficacy for quick and precise diagnosis of various waterborne diseases. The development of various combinations of nanoparticle drugs has multiple-fold benefit than a single antibiotic administered in diarrhea. This review article provides a bird’s eye view on the recent advancements of nanotechnology-based treatment and diagnosis of waterborne diseases. Keywords: Nanotechnology, waterborne diseases, drug delivery, infectionPublikováno
Číslo
Sekce
Licence
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. _______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |